Second Hematopoietic Stem Cell Transplantation for Leukemia Relapsing after Myeloablative T Cell Depleted Transplants Does Not Prolong Survival

por McIver, Zachariah A., Yin, Fang, Hughes, Thomas, Battiwalla, Minoo, Ito, Sawa, Koklanaris, Eleftheria, Haggerty, Janice, Hensel, Nancy F., Barrett, A. John
Publicado em 2013

Radiation Exposure from Diagnostic Procedures following Allogeneic Stem Cell Transplantation – How Much Is Acceptable?

por Battiwalla, Minoo, Fakhrejahani, Farhad, Jain, Natasha A, Klotz, Jeffrey K., Pophali, Priyanka A, Draper, Debbie, Haggerty, Janice, McIver, Zachariah, Jelinek, James, Chawla, Kamna, Ito, Sawa, Barrett, John
Publicado em 2013

The Clinical and Financial Burden of Preemptive Management of CMV Disease after Allogeneic Stem Cell Transplantation – Implications for Preventative Treatment Approaches

por Jain, Natasha A., Lu, Kit, Ito, Sawa, Muranski, Pawel, Hourigan, Christopher S., Haggerty, Janice, Chokshi, Puja D., Ramos, Catalina, Cho, Elena, Cook, Lisa, Childs, Richard, Battiwalla, Minoo, Barrett, A. John
Publicado em 2014